COVID-19 hos børn ogog ungeunge
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 183 KB, PDF-dokument
Children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are usually asymptomatic or have mild coronavirus disease (COVID-19) with low rates of hospitalization and death. Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe complication of SARS-CoV-2 infection. This paper reviews an excerpt of the literature on disease burden and complications following COVID-19 in children and adolescents aged 0-17 years, in addition to the effects and adverse drug reactions of BNT162b2 and mRNA-1273 vaccinations among children and adolescents aged 5-17 years.
Bidragets oversatte titel | COVID-19 among children and adolescents |
---|---|
Originalsprog | Dansk |
Artikelnummer | V11210858 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 184 |
Udgave nummer | 9 |
Antal sider | 6 |
ISSN | 0041-5782 |
Status | Udgivet - 2022 |
- Adolescent, BNT162 Vaccine, COVID-19/complications, Child, Child, Preschool, Hospitalization, Humans, Infant, Infant, Newborn, SARS-CoV-2, Systemic Inflammatory Response Syndrome
Forskningsområder
Links
- https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-03/v11210858_web.pdf
Forlagets udgivne version
ID: 325841422